For example, SCS was performed on patients with non-small cell lung cancer (NSCLC), which identified 12 key genes including MS4A1, CCL5, and GZMB as potential diagnostic and prognostic biomarkers (Sultana et al., 2023). This evidence concerns the gene MS4A1 and non-small cell lung carcinoma.